Update on Psoriasis Therapy : A Perspective from the USA
スポンサーリンク
概要
- 論文の詳細を見る
Because physicians from different nations frequently acquire the use of a new medication at different times, the international exchange of experiences with the new medication is valuable in max-imizing its efficacy worldwide. In recent years, many new therapeutic agents have been approved for treating psoriasis in the United States. These include the topical agent calcipotriol and the systemic agents acitretin and cyclosporine. In addition to new agents, a new therapeutic paradigm, sequential therapy, has been introduced recently. It is the hope of the authors that by sharing this paradigm and experiences with these agents in the United States, dermatologists in Japan may gain further insight into optimizing the use of these agents in the treatment of psoriasis.
- The Keio Journal of Medicineの論文
- 2000-03-01
著者
-
Liao Wennie
University Of Michigan Medical Center
-
Koo John
米国
-
KOO John
Psoriasis Treatment Center, Department of Dermatology, University of California San Francisco Medica